Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat.
A sub-chronic administration of phencyclidine to the rat brings about enduring pathophysiological and cognitive changes that resemble some features of schizophrenia. The present study aimed to determine whether the behavioural consequence of this phencyclidine regime extends to a long-term disruption of social interaction that might provide a parallel with some negative symptoms of the disease. Rats were treated with phencyclidine (2mg/kg bi-daily for 1 week) or vehicle followed by a drug-free period. Social interaction was assessed 24h, 1 week, 3 weeks and 6 weeks post-treatment. A long-lasting disturbance of social behaviour was observed in the phencyclidine group, namely more contact and non-contact interaction with an unfamiliar target rat at all time points. Six weeks post-phencyclidine, analysis of brains showed a reduction in expression of parvalbumin immunoreactive neurons in the hippocampus with significant reductions localised to the CA1 and dentate gyrus regions. These results show that sub-chronic phencyclidine produces long-lasting disruptions in social interaction that, however, do not model the social withdrawal seen in patients with schizophrenia. These disturbances of social behaviour may be associated with concurrent pathophysiological brain changes.
Jenkins
Trisha A
TA
Division of Psychiatry and Neuroscience, Queen's University, Belfast, Northern Ireland, United Kingdom. t.jenkins@qub.ac.uk
Harte
Michael K
MK
McKibben
Claire E
CE
Elliott
Jennifer J
JJ
Reynolds
Gavin P
GP
D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D004195:Disease Models, Animal; D006213:Hallucinogens / Q000008:administration & dosage*; D006624:Hippocampus / Q000378:metabolism; D007398:Interpersonal Relations; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010320:Parvalbumins / Q000378:metabolism; D010622:Phencyclidine / Q000008:administration & dosage*; D051381:Rats; D012559:Schizophrenia / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D013997:Time Factors
D006213:Hallucinogens; D010320:Parvalbumins; D010622:Phencyclidine